Boston Scientific Corporation (BSX) investor relations documents from the company's IR site: 6 presentations, 11 press releases; latest deck 2026-07-29. Read in-app with summaries. First-party data.
Q2 2026 Financial and Operational Highlights — Boston Scientific reported Q2 2026 net sales of $5.442 billion, a 7.5% increase, and raised its full-year 2026 adjusted EPS guidance to $3.28–$3.32.
BSX overview · BSX earnings · BSX financials · BSX KPIs · BSX ownership · BSX peers · BSX filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.